Tocilizumab, also known by its brand name Actemra, is a medication used to treat rheumatoid arthritis, a chronic autoimmune disorder that causes inflammation and pain in the joints. It belongs to a class of medications called interleukin-6 (IL-6) inhibitors, which work by blocking the action of IL-6, a protein that promotes inflammation.
Studies have shown that patients with severe COVID-19 have elevated levels of IL-6, suggesting that Tocilizumab may be effective in reducing inflammation and improving outcomes in these patients. tocil abg hot